Eledon Pharmaceuticals, Inc. (ELDN) Reports In-Line Q3 EPS

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q3 EPS of ($0.32), in-line with the analyst estimate of ($0.32).

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.

You May Also Be Interested In

• SLM (SLM) Misses Q2 EPS by 16c; offers guidance
• United Bancorp (UBCP) Reports Q2 EPS of $0.36
• Summit Therapeutics (SMMT) Reports In-Line Q2 EPS